Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazanin Mojtabavi

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Biomarker Insights|December 15, 2022
Aberrant expression of miR-138 as a novel diagnostic biomarker in systemic sclerosisParia Bayati, Hadi Poormoghim, Nazanin Mojtabavi
Stem Cell Research & Therapy|June 17, 2024
Stem cell-based therapy for fibrotic diseases: mechanisms and pathwaysMarjan Taherian, Paria Bayati, Nazanin Mojtabavi
International Journal of Immunopathology and Pharmacology|August 20, 2024
Immunomodulatory effects of the induced pluripotent stem cells through expressing IGF-related factors and IL-10 in vitroParia Bayati, Marjan Taherian, Nazanin Mojtabavi
Pathophysiology : the Official Journal of the International Society for Pathophysiology|June 21, 2017
Interleukin-6 participation in pathology of ocular diseasesForouhe Zahir-Jouzdani, Fatemeh Atyabi, Nazanin Mojtabavi
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Long-lived Th2 memory in experimental allergic asthmaNazanin Mojtabavi, Gerhard Dekan, Georg Stingl, et al.
International Reviews of Immunology|November 15, 2021
The potential targets in immunotherapy of atherosclerosisAzin Aghamajidi, Melika Gorgani, Faezeh Shahba, et al.
Frontiers in Immunology|May 24, 2021
Implications the Role of miR-155 in the Pathogenesis of Autoimmune DiseasesSalar Pashangzadeh, Morteza Motallebnezhad, Fatemeh Vafashoar, et al.
Stem Cell Research & Therapy|November 29, 2023
Induced pluripotent stem cells modulate the Wnt pathway in the bleomycin-induced model of idiopathic pulmonary fibrosisParia Bayati, Marjan Taherian, Mansoureh Soleimani, et al.
Scientific Reports|November 7, 2022
MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosisParia Bayati, Mahsa Kalantari, Mohammad-Ali Assarehzadegan, et al.
Rheumatology International|April 11, 2016
Survival and causes of death in systemic sclerosis patients: a single center registry report from IranHadi Poormoghim, Elham Andalib, Arash Jalali, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Biomarker Insights|December 15, 2022
Aberrant expression of miR-138 as a novel diagnostic biomarker in systemic sclerosisParia Bayati, Hadi Poormoghim, Nazanin Mojtabavi
Stem Cell Research & Therapy|June 17, 2024
Stem cell-based therapy for fibrotic diseases: mechanisms and pathwaysMarjan Taherian, Paria Bayati, Nazanin Mojtabavi
International Journal of Immunopathology and Pharmacology|August 20, 2024
Immunomodulatory effects of the induced pluripotent stem cells through expressing IGF-related factors and IL-10 in vitroParia Bayati, Marjan Taherian, Nazanin Mojtabavi
Pathophysiology : the Official Journal of the International Society for Pathophysiology|June 21, 2017
Interleukin-6 participation in pathology of ocular diseasesForouhe Zahir-Jouzdani, Fatemeh Atyabi, Nazanin Mojtabavi
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Long-lived Th2 memory in experimental allergic asthmaNazanin Mojtabavi, Gerhard Dekan, Georg Stingl, et al.
International Reviews of Immunology|November 15, 2021
The potential targets in immunotherapy of atherosclerosisAzin Aghamajidi, Melika Gorgani, Faezeh Shahba, et al.
Frontiers in Immunology|May 24, 2021
Implications the Role of miR-155 in the Pathogenesis of Autoimmune DiseasesSalar Pashangzadeh, Morteza Motallebnezhad, Fatemeh Vafashoar, et al.
Stem Cell Research & Therapy|November 29, 2023
Induced pluripotent stem cells modulate the Wnt pathway in the bleomycin-induced model of idiopathic pulmonary fibrosisParia Bayati, Marjan Taherian, Mansoureh Soleimani, et al.
Scientific Reports|November 7, 2022
MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosisParia Bayati, Mahsa Kalantari, Mohammad-Ali Assarehzadegan, et al.
Rheumatology International|April 11, 2016
Survival and causes of death in systemic sclerosis patients: a single center registry report from IranHadi Poormoghim, Elham Andalib, Arash Jalali, et al.
Pageof 4